Literature DB >> 1528645

Pseudomonas infections in children with human immunodeficiency virus infection.

E Roilides1, K M Butler, R N Husson, B U Mueller, L L Lewis, P A Pizzo.   

Abstract

Thirteen bacteremias and 25 nonbacteremic infections caused by Pseudomonas spp. occurred in 22 of 236 children with human immunodeficiency virus infection with a rate of infection of 0.098 (bacteremia, 0.030) per patient year. Four patients were neutropenic (less than 500/microliters). Central venous catheter (CVC)-related infections were most frequent (n = 20) followed by otitis externa (n = 6) and pneumonia (n = 5). Pseudomonas aeruginosa was the most common isolate and caused both CVC-related and CVC-unrelated infections, whereas other Pseudomonas spp. and Xanthomonas maltophilia were almost exclusively associated with CVC-related infections. The children who received appropriate therapy had a favorable outcome. In 7 CVC-related infections (35%) the catheter was removed. Pseudomonas spp. are of increasing importance in human immunodeficiency virus-infected children causing significant morbidity and increased hospitalization. These infections may be life-threatening if appropriate therapy is not vigorously initiated.

Entities:  

Mesh:

Year:  1992        PMID: 1528645     DOI: 10.1097/00006454-199207000-00008

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  12 in total

1.  Pseudomonas aeruginosa exoenzyme S is a biglutamic acid ADP-ribosyltransferase.

Authors:  J Radke; K J Pederson; J T Barbieri
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

2.  Identification and detection of Stenotrophomonas maltophilia by rRNA-directed PCR.

Authors:  P W Whitby; K B Carter; J L Burns; J A Royall; J J LiPuma; T L Stull
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

3.  Growth phase-dependent invasion of Pseudomonas aeruginosa and its survival within HeLa cells.

Authors:  U Ha; S Jin
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

4.  Human monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal pseudomonas sepsis.

Authors:  S Hemachandra; K Kamboj; J Copfer; G Pier; L L Green; J R Schreiber
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

Review 5.  Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia.

Authors:  M Denton; K G Kerr
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

6.  Pseudomonas spp. complications in patients with HIV disease: an eight-year clinical and microbiological survey.

Authors:  R Manfredi; A Nanetti; M Ferri; F Chiodo
Journal:  Eur J Epidemiol       Date:  2000-02       Impact factor: 8.082

7.  DsbA of Pseudomonas aeruginosa is essential for multiple virulence factors.

Authors:  Un-Hwan Ha; Yanping Wang; Shouguang Jin
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

8.  Isolation and characterization of novel giant Stenotrophomonas maltophilia phage phiSMA5.

Authors:  Hsiao-Chuan Chang; Chiy-Rong Chen; Juey-Wen Lin; Gwan-Han Shen; Kai-Ming Chang; Yi-Hsiung Tseng; Shu-Fen Weng
Journal:  Appl Environ Microbiol       Date:  2005-03       Impact factor: 4.792

9.  Expression of recombinant exoenzyme S of Pseudomonas aeruginosa.

Authors:  S M Kulich; D W Frank; J T Barbieri
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

10.  Immunogenicity of tetanus toxoid conjugates of anti-idiotypes that mimic Pseudomonas aeruginosa surface polysaccharides.

Authors:  J R Schreiber; P Dahlhauser
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.